Sparrow Pharmaceuticals raises $95M in Series B financing co-led by RA Capital Management and Forbion to develop clofutriben for type 2 diabetes treatment.
Amount Raised
$95 Million
Round Type
Series B
PortlandHealthcareHealth CareInvestors
Description
Sparrow Pharmaceuticals, a Portland, OR-based cardiometabolic therapeutics company, raised $95M Series B financing. The round was co-led by RA Capital Management and Forbion with participation from existing investors including OrbiMed, RiverVest, and US Venture Partners. The funds will support development of its lead candidate clofutriben for treating type 2 diabetes with elevated cortisol. Led by CEO Robert Jacks, the company focuses on improving outcomes for diabetes patients.
Quick answer
Sparrow Pharmaceuticals raised $95 Million in a Series B round, dated September 24, 2025. Investors: US Venture Partners, Orbimed, RiverVest, Forbion and RA Capital Management. Sparrow Pharmaceuticals is based in Portland, Oregon, United States.
- How much did Sparrow Pharmaceuticals raise?
- Sparrow Pharmaceuticals raised $95 Million in a Series B round on September 24, 2025.
- Who invested in Sparrow Pharmaceuticals?
- US Venture Partners, Orbimed, RiverVest, Forbion and RA Capital Management are named as investors in this round.
- What does Sparrow Pharmaceuticals do?
- Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such..
- Where is Sparrow Pharmaceuticals based and how big is it?
- Sparrow Pharmaceuticals is based in Portland, Oregon, United States.
- Who are the decision-makers at Sparrow Pharmaceuticals?
- Fundz holds 1 contact at Sparrow Pharmaceuticals, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Sparrow Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Atrility Medical raised $1M on November 7, 2025.
- Peca Labs raised $2.7M on November 6, 2025.
- Pelthos Therapeutics raised $18M on November 6, 2025.
- Beyond Air raised $32M (Debt Financing) on November 5, 2025.
- Phio Pharmaceuticals raised $1.4M on November 4, 2025.
- Epalex raised $1.2M on October 31, 2025.
Who to call at Sparrow Pharmaceuticals, and when
A new round usually means Sparrow Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sparrow Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sparrow Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sparrow Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sparrow Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSparrow Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.